SadraSashaJazayeriMD

Clinical Trials

• A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) Start of enrollment: 2005 Mar 01

  Completed

• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis Start of enrollment: 2005 May 25

  Terminated

• Psoriasis Longitudinal Assessment and Registry Start of enrollment: 2007 Jun 21

  Active, not recruiting

• Chronic Plaque Psoriasis (Ps) Registry Start of enrollment: 2008 Sep 26

  Completed

• Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients Start of enrollment: 2012 May 01

  Terminated

  Phase 3

• An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life Start of enrollment: 2013 Jul 01

  Completed

• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira Start of enrollment: 2013 Dec 01

  Completed

  Phase 3

• A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis Start of enrollment: 2014 May 01

  Completed

  Phase 2

• Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis Start of enrollment: 2015 Aug 01

  Completed

  Phase 3

• Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris Start of enrollment: 2015 May 01

  Completed

  Phase 3

• Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis Start of enrollment: 2016 Aug 17

  Completed

  Phase 3

• A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis Start of enrollment: 2016 Sep 14

  Completed

  Phase 2

• A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris Start of enrollment: 2016 Dec 27

  Completed

  Phase 3

• A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris Start of enrollment: 2017 Mar 21

  Completed

  Phase 3

• A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004) Start of enrollment: 2017 Sep 15

  Completed

  Phase 3

• Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2018 May 08

  Completed

  Phase 3

• Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) Start of enrollment: 2018 Aug 13

  Active, not recruiting

  Phase 3

• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2018 Nov 09

  Completed

  Phase 4

• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2018 Jul 26

  Completed

  Phase 3

• A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis Start of enrollment: 2019 May 20

  Completed

  Phase 2

• A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2019 May 13

  Completed

  Phase 3

• A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis Start of enrollment: 2019 Jun 27

  Completed

  Phase 2

• Join now to see all